(Q35085388)

6 August 2017

The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women (English)

1 reference

6 August 2017

Jeffrey A Tice

1

1 reference

6 August 2017

Warren Browner

series ordinal

2

1 reference

6 August 2017

Russell P Tracy

series ordinal

3

1 reference

6 August 2017

Steven R Cummings

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

American Journal of Medicine

6 August 2017

1 reference

6 August 2017

114

1 reference

6 August 2017

3

1 reference

6 August 2017

199-205

1 reference

Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Vitamin E consumption and the risk of coronary heart disease in men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Vitamin E consumption and the risk of coronary disease in women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Inflammation in cardiovascular disease: cart, horse, or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Is C-reactive protein specific for vascular disease in women?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

A case-cohort design for epidemiologic cohort studies and disease prevention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Opportunities for enhancing efficiency and reducing cost in large scale disease prevention trials: a statistical perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Raised C-reactive protein levels in serum from smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Hormone replacement therapy, inflammation, and hemostasis in elderly women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Pleiotropic effects of statins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Direct proinflammatory effect of C-reactive protein on human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

The role of diagnostic inconsistency in changing rates of occurrence for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Prospective study of necropsy audit of geriatric inpatient deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

inferred from DOI database lookup

7 January 2021

based on heuristic

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901497-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(02)01497-3

1 reference

6 August 2017

1 reference